Fig. 3From: Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology a The predicted binding mode of Indinavir in VP24 of Ebola (a) and (b) the binding mode of Indinavir in HIV protease (PDB id 2AVO)Back to article page